{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:26:47Z","timestamp":1789921607964,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,5,4]],"date-time":"2006-05-04T00:00:00Z","timestamp":1146700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s00401-006-0070-z","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T14:09:05Z","timestamp":1146665345000},"page":"510-518","source":"Crossref","is-referenced-by-count":19,"title":["Relative paucity of tau accumulation in the small areas with abundant A\u03b242-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology"],"prefix":"10.1007","volume":"111","author":[{"given":"Kenichi","family":"Oshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Haga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eizo","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotake","family":"Uchikado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Niizato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heii","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,5,4]]},"reference":[{"key":"70_CR1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(96)12474-5","volume":"206","author":"H Akiyama","year":"1996","unstructured":"Akiyama H, Schwab C, Kondo H, Mori H, Kametani F, Ikeda K, McGeer PL (1996) Granules in glial cells of patients with Alzheimer\u2019s disease are immunopositive for C-terminal sequences of beta-amyloid protein. Neurosci Lett 206:169\u2013172","journal-title":"Neurosci Lett"},{"key":"70_CR2","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1023\/A:1021910729963","volume":"22","author":"H Akiyama","year":"1997","unstructured":"Akiyama H, Mori H, Sahara N, Kondo H, Ikeda K, Nishimura T, Oda T, McGeer PL (1997) Variable deposition of amyloid beta-protein (A beta) with the carboxy-terminus that ends at residue valine40 (A beta 40) in the cerebral cortex of patients with Alzheimer\u2019s disease: a double-labeling immunohistochemical study with antibodies specific for A beta 40 and the A beta that ends at residues alanine42\/threonine43 (A beta 42). Neurochem Res 22:1499\u20131506","journal-title":"Neurochem Res"},{"key":"70_CR3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5","volume":"25","author":"H Akiyama","year":"1999","unstructured":"Akiyama H, Mori H, Saido T, Kondo H, Ikeda K, McGeer PL (1999) Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer\u2019s disease. Glia 25:324\u2013331","journal-title":"Glia"},{"issue":"Suppl 1","key":"70_CR4","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/00002093-200000001-00008","volume":"14","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Arai T, Kondo H, Tanno E, Haga C, Ikeda K (2000) Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis Assoc Disord 14 (Suppl 1):S47\u2013S53","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"70_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm0204-117","volume":"10","author":"H Akiyama","year":"2004","unstructured":"Akiyama H, McGeer PL (2004) Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease. Nat Med 10:117\u2013118","journal-title":"Nat Med"},{"key":"70_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0796-9","volume":"107","author":"J Attems","year":"2004","unstructured":"Attems J, Jellinger KA (2004) Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology\u2014a pilot study. Acta Neuropathol 107:83\u201390","journal-title":"Acta Neuropathol"},{"key":"70_CR7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00401-004-0822-6","volume":"107","author":"J Attems","year":"2004","unstructured":"Attems J, Lintner F, Jellinger KA (2004) Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol 107:283\u2013291","journal-title":"Acta Neuropathol"},{"key":"70_CR8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00401-005-1064-y","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J, Jellinger KA, Lintner F (2005) Alzheimer\u2019s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 110:222\u2013231","journal-title":"Acta Neuropathol"},{"key":"70_CR9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.2005.03407.x","volume":"95","author":"S Barghorn","year":"2005","unstructured":"Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, Janson B, Bahr M, Schmidt M, Bitner RS, Harlan J, Barlow E, Ebert U, Hillen H (2005) Globular amyloid beta-peptide oligomer\u2014a homogenous and stable neuropathological protein in Alzheimer\u2019s disease. J Neurochem 95:834\u2013847","journal-title":"J Neurochem"},{"key":"70_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"70_CR11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0896-6273(95)90232-5","volume":"14","author":"J Busciglio","year":"1995","unstructured":"Busciglio J, Lorenzo A, Yeh J, Yankner BA (1995) beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14:879\u2013888","journal-title":"Neuron"},{"key":"70_CR12","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.96.24.14088","volume":"96","author":"ME Calhoun","year":"1999","unstructured":"Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 96:14088\u201314093","journal-title":"Proc Natl Acad Sci USA"},{"key":"70_CR13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0002-9440(10)64053-9","volume":"158","author":"R Christie","year":"2001","unstructured":"Christie R, Yamada M, Moskowitz M, Hyman B (2001) Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am J Pathol 158:1065\u20131071","journal-title":"Am J Pathol"},{"key":"70_CR14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2990.2004.00614.x","volume":"31","author":"M Christoforidis","year":"2005","unstructured":"Christoforidis M, Schober R, Krohn K (2005) Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 31:11\u201319","journal-title":"Neuropathol Appl Neurobiol"},{"key":"70_CR15","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","volume":"23","author":"JR Cirrito","year":"2003","unstructured":"Cirrito JR, May PC, O\u2019Dell MA, Taylor JW, Parsadanian M, Cramer JW, Audia JE, Nissen JS, Bales KR, Paul SM, DeMattos RB, Holtzman DM (2003) In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J Neurosci 23:8844\u20138853","journal-title":"J Neurosci"},{"key":"70_CR16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","volume":"48","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Shoepp DD, PaulSM, Mennerick S, Holtzman DM (2005) Synaptic activity regulates interstitial fluid amyloid-\u03b2 levels in vivo. Neuron 48:913\u2013922","journal-title":"Neuron"},{"key":"70_CR17","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","volume":"277","author":"KN Dahlgren","year":"2002","unstructured":"Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277:32046\u201332053","journal-title":"J Biol Chem"},{"key":"70_CR18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","volume":"43","author":"R Deane","year":"2004","unstructured":"Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand WE, Zlokovic BV (2004) LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43:333\u2013344","journal-title":"Neuron"},{"key":"70_CR19","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1126\/science.1067568","volume":"295","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM (2002) Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer\u2019s disease. Science 295:2264\u20132267","journal-title":"Science"},{"key":"70_CR20","first-page":"113","volume":"23","author":"RA Galuske","year":"2004","unstructured":"Galuske RA, Drach LM, Nichtweiss M, Marquardt G, Franz K, Bohl J, Schlote W (2004) Colocalization of different types of amyloid in the walls of cerebral blood vessels of patients suffering from cerebral amyloid angiopathy and spontaneous intracranial hemorrhage: a report of 5 cases. Clin Neuropathol 23:113\u2013119","journal-title":"Clin Neuropathol"},{"key":"70_CR21","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J Gotz","year":"2001","unstructured":"Gotz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Abeta 42 fibrils. Science 293:1491\u20131495","journal-title":"Science"},{"key":"70_CR22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijdevneu.2004.07.013","volume":"22","author":"J Gotz","year":"2004","unstructured":"Gotz J, Schild A, Hoerndli F, Pennanen L (2004) Amyloid-induced neurofibrillary tangle formation in Alzheimer\u2019s disease: insight from transgenic mouse and tissue-culture models. Int J Dev Neurosci 22:453\u2013465","journal-title":"Int J Dev Neurosci"},{"key":"70_CR23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"70_CR24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1385\/JMN:20:2:203","volume":"20","author":"J Hardy","year":"2003","unstructured":"Hardy J (2003) The relationship between amyloid and tau. J Mol Neurosci 20:203\u2013206","journal-title":"J Mol Neurosci"},{"key":"70_CR25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-7091-6467-9_15","volume":"53","author":"K Iqbal","year":"1998","unstructured":"Iqbal K, Alonso AC, Gong CX, Khatoon S, Pei JJ, Wang JZ, Grundke-Iqbal I (1998) Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. J Neural Transm Suppl 53:169\u2013180","journal-title":"J Neural Transm Suppl"},{"key":"70_CR26","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","volume":"292","author":"N Iwata","year":"2001","unstructured":"Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC (2001) Metabolic regulation of brain Abeta by neprilysin. Science 292:1550\u20131552","journal-title":"Science"},{"key":"70_CR27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/01.WNL.0000151958.79884.86","volume":"64","author":"T Katsuno","year":"2005","unstructured":"Katsuno T, Morishima-Kawashima M, Saito Y, Yamanouchi H, Ishiura S, Murayama S, Ihara Y (2005) Independent accumulations of tau and amyloid beta-protein in the human entorhinal cortex. Neurology 64:687\u2013692","journal-title":"Neurology"},{"key":"70_CR28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","volume":"11","author":"FM LaFerla","year":"2005","unstructured":"LaFerla FM, Oddo S (2005) Alzheimer\u2019s disease: Abeta, tau and synaptic sysfunction. Trends Mol Med 11:170\u2013176","journal-title":"Trends Mol Med"},{"key":"70_CR29","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487\u20131491","journal-title":"Science"},{"key":"70_CR30","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113\u20131124","journal-title":"Neurology"},{"key":"70_CR31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, participating CERAD neuropathologists (1991) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"70_CR32","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1016\/S0021-9258(18)41896-0","volume":"267","author":"H Mori","year":"1992","unstructured":"Mori H, Takio K, Ogawara M, Selkoe DJ (1992) Mass spectrometry of purified amyloid beta protein in Alzheimer\u2019s disease. J Biol Chem 267:17082\u201317086","journal-title":"J Biol Chem"},{"key":"70_CR33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1620\/tjem.174.251","volume":"174","author":"H Mori","year":"1994","unstructured":"Mori H, Ishii K, Tomiyama T, Furiya Y, Sahara N, Asano S, Endo N, Shirasawa T, Takio K (1994) Racemization: its biological significance on neuropathogenesis of Alzheimer\u2019s disease. Tohoku J Exp Med 174:251\u2013262","journal-title":"Tohoku J Exp Med"},{"key":"70_CR34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM (2004) A\u03b2 immunotherapy leads to cliearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43:321\u2013332","journal-title":"Neuron"},{"key":"70_CR35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archneur.1995.00540310076019","volume":"52","author":"JM Olichney","year":"1995","unstructured":"Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ (1995) Cerebral infarction in Alzheimer\u2019s disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 52:702\u2013708","journal-title":"Arch Neurol"},{"key":"70_CR36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1749-6632.1997.tb48511.x","volume":"826","author":"JM Olichney","year":"1997","unstructured":"Olichney JM, Ellis RJ, Katzman R, Sabbagh MN, Hansen L (1997) Types of cerebrovascular lesions associated with severe cerebral amyloid angiopathy in Alzheimer\u2019s disease. Ann N Y Acad Sci 826:493\u2013497","journal-title":"Ann N Y Acad Sci"},{"key":"70_CR37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2990.2003.00424.x","volume":"29","author":"SD Preston","year":"2003","unstructured":"Preston SD, Steart PV, Wilkinson A, Nicoll JA, Weller RO (2003) Capillary and arterial cerebral amyloid angiopathy in Alzheimer\u2019s disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol 29:106\u2013117","journal-title":"Neuropathol Appl Neurobiol"},{"key":"70_CR38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease; genes, proteins, and therapy. Physiol Rev 81:741\u2013766","journal-title":"Physiol Rev"},{"key":"70_CR39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0197-4580(95)00055-J","volume":"16","author":"LM Shaffer","year":"1995","unstructured":"Shaffer LM, Dority MD, Gupta-Bansal R, Frederickson RCA, Younkin SG, Brunden KR (1995) Amyloid \u03b2 protein (A\u03b2) removal by neuroglial cells in culture. Neurobiol Aging 16:737\u2013745","journal-title":"Neurobiol Aging"},{"key":"70_CR40","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV (2000) Clearance of Alzheimer\u2019s amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489\u20131499","journal-title":"J Clin Invest"},{"key":"70_CR41","doi-asserted-by":"crossref","first-page":"21895","DOI":"10.1074\/jbc.M008511200","volume":"276","author":"K Shirotani","year":"2001","unstructured":"Shirotani K, Tsubuki S, Iwata N, Takaki Y, Harigaya W, Maruyama K, Kiryu-Seo S, Kiyama H, Iwata H, Tomita T, Iwatsubo T, Saido TC (2001) Neprilysin degrades both amyloid beta peptides 1\u201340 and 1\u201342 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J Biol Chem 276:21895\u201321901","journal-title":"J Biol Chem"},{"key":"70_CR42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR, Ghebremedhin E, Rub U, Yamaguchi H, Tredici KD, Braak H (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61:282\u2013293","journal-title":"J Neuropathol Exp Neurol"},{"key":"70_CR43","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","volume":"62","author":"DR Thal","year":"2003","unstructured":"Thal DR, Ghebremedhin E, Orantes M, Wiestler OD (2003) Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis\/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62:1287\u20131301","journal-title":"J Neuropathol Exp Neurol"},{"key":"70_CR44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neulet.2003.08.048","volume":"352","author":"J Tian","year":"2003","unstructured":"Tian J, Shi J, Bailey K, Mann DM (2003) Negative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer\u2019s disease. Neurosci Lett 352:137\u2013140","journal-title":"Neurosci Lett"},{"key":"70_CR45","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/jnnp.2003.012096","volume":"75","author":"J Tian","year":"2004","unstructured":"Tian J, Shi J, Bailey K, Lendon CL, Pickering-Brown SM, Mann DM (2004) Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 75:696\u2013699","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"70_CR46","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.410300503","volume":"30","author":"JP Vonsattel","year":"1991","unstructured":"Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr (1991) Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 30:637\u2013649","journal-title":"Ann Neurol"},{"key":"70_CR47","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535\u2013539","journal-title":"Nature"},{"key":"70_CR48","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9440(10)65616-7","volume":"153","author":"RO Weller","year":"1998","unstructured":"Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE (1998) Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer\u2019s disease. Am J Pathol 153:725\u2013733","journal-title":"Am J Pathol"},{"key":"70_CR49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2990.2005.00663.x","volume":"31","author":"S Williams","year":"2005","unstructured":"Williams S, Chalmers K, Wilcock GK, Love S (2005) Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 31:414\u2013421","journal-title":"Neuropathol Appl Neurobiol"},{"key":"70_CR50","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/87945","volume":"7","author":"T Wyss-Coray","year":"2001","unstructured":"Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, McConlogue L, Masliah E, Mucke L (2001) TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med 7:612\u2013618","journal-title":"Nat Med"},{"key":"70_CR51","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","volume":"89","author":"BV Zlokovic","year":"2004","unstructured":"Zlokovic BV (2004) Clearing amyloid through the blood-brain barrier. J Neurochem 89:807\u2013811","journal-title":"J Neurochem"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-006-0070-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-006-0070-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-006-0070-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T15:38:36Z","timestamp":1627313916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-006-0070-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,4]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s00401-006-0070-z","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,4]]}}}